Stephen Schultz

Shares of GW Pharmaceuticals plc (NASDAQ: GWPH) sold off Tuesday after the release of an abstract presented at the American Epilepsy Society meeting. The abstract showed evidence of interaction between GW Pharma's lead anti-epilepsy treatment, Epidiolex, and several other anti-epilepsy drugs...